Effect of Estradiol in an Azoxymethane/Dextran Sulfate Sodium-Treated Mouse Model of Colorectal Cancer: Implication for Sex Difference in Colorectal Cancer Development
1
조회
0
다운로드
9
인용
0
참고문헌
키워드
초록
Purpose This study demonstrates that estradiol downregulates inflammation and inhibits colorectal cancer (CRC) development in azoxymethane/dextran sulfate sodium (AOM/DSS) mouse model. Materials and Methods AOM/DSS-treated male and female mice were sacrificed at weeks 2, 10, and 16, to assess estrogen effects on colitis and carcinogenesis. Macroscopic and histologic severity of colitis and Western blot and quantitative real-time polymerase chain reaction were evaluated, to measure inflammatory mediators and cytokines. Results Compared with AOM/DSS-treated male mice (M-AOM/DSS group), AOM/DSS-treated male mice with estradiol administration (M-AOM/DSS+estr group) displayed at week 2 significantly decreased severity of colitis. At weeks 10 and 16, AOM/DSS-treated female mice (F-AOM/DSS group) and the M-AOM/DSS+estr group showed significantly lower tumor multiplicity compared with the M-AOM/DSS group. At week 2, F-AOM/DSS group had a lower level of nuclear factor-B (NF-B) expression and higher level of nuclear factor erythroid 2-related factor 2 (Nrf2) expression, compared to the M-AOM/DSS group. At week 2, expression levels of NF-B and its related mediators decreased in the M-AOM/DSS+estr group, while levels of Nrf2 and Nrf2-related anti-oxidant enzymes increased. In addition, estradiol significantly increased Nod-like receptor protein 3 (NLRP3) inflammasome expressions in AOM/DSS-treated male mice. In contrast, at weeks 10 and 16, Nrf2 and its-related anti-oxidant enzymes and NLRP3 inflammasome were highly expressed in M-AOM/DSS group and in F-AOM/DSS group, who developed cancer. Conclusion The data suggest that estradiol inhibits the initiation of CRC by regulating Nrf2-related pathways. Moreover, these imply the dual role of Nrf2 and NLRP3 inflammasome, including promotion of tumor progression upon tumor initiation.
Abstract
Purpose This study demonstrates that estradiol downregulates inflammation and inhibits colorectal cancer (CRC) development in azoxymethane/dextran sulfate sodium (AOM/DSS) mouse model. Materials and Methods AOM/DSS-treated male and female mice were sacrificed at weeks 2, 10, and 16, to assess estrogen effects on colitis and carcinogenesis. Macroscopic and histologic severity of colitis and Western blot and quantitative real-time polymerase chain reaction were evaluated, to measure inflammatory mediators and cytokines. Results Compared with AOM/DSS-treated male mice (M-AOM/DSS group), AOM/DSS-treated male mice with estradiol administration (M-AOM/DSS+estr group) displayed at week 2 significantly decreased severity of colitis. At weeks 10 and 16, AOM/DSS-treated female mice (F-AOM/DSS group) and the M-AOM/DSS+estr group showed significantly lower tumor multiplicity compared with the M-AOM/DSS group. At week 2, F-AOM/DSS group had a lower level of nuclear factor-B (NF-B) expression and higher level of nuclear factor erythroid 2-related factor 2 (Nrf2) expression, compared to the M-AOM/DSS group. At week 2, expression levels of NF-B and its related mediators decreased in the M-AOM/DSS+estr group, while levels of Nrf2 and Nrf2-related anti-oxidant enzymes increased. In addition, estradiol significantly increased Nod-like receptor protein 3 (NLRP3) inflammasome expressions in AOM/DSS-treated male mice. In contrast, at weeks 10 and 16, Nrf2 and its-related anti-oxidant enzymes and NLRP3 inflammasome were highly expressed in M-AOM/DSS group and in F-AOM/DSS group, who developed cancer. Conclusion The data suggest that estradiol inhibits the initiation of CRC by regulating Nrf2-related pathways. Moreover, these imply the dual role of Nrf2 and NLRP3 inflammasome, including promotion of tumor progression upon tumor initiation.
참고문헌 (30)
- Alteri R, "Colorectal cancer facts and figures 2014-2016" (2014), American Cancer Society
- Gierisch JM, "Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers : a systematic review", Cancer Epidemiol Biomarkers Prev, 22, pp.1931~1943 (2013)
- Chlebowski RT, "Estrogen plus progestin and colorectal cancer in postmenopausal women", N Engl J Med, 350, pp.991~1004 (2004)
- Weyant MJ, "Reciprocal expression of ERalpha and ERbeta is associated with estrogen-mediated modulation of intestinal tumorigenesis", Cancer Res, 61, pp.2547~2551 (2001)
- Amos-Landgraf JM, "Sex disparity in colonic adenomagenesis involves promotion by male hormones, not protection by female hormones", Proc Natl Acad Sci U S A, 111, pp.16514~16519 (2014)
- Sun Min Lee, "The Effect of Sex on the Azoxymethane", Dextran Sulfate Sodium-treated Mice Model of Colon Cancer, 2016, pp.21(4), 271~278[DOI]
- Wu J, "Estrogen increases Nrf2 activity through activation of the PI3K pathway in MCF-7 breast cancer cells", Exp Cell Res, 328, pp.351~360 (2014)
- Cho MK, "Role of Galpha12 and Galpha13 as novel switches for the activity of Nrf2, a key antioxidative transcription factor", Mol Cell Biol, 27, pp.6195~6208 (2007)
- Li T, "Age and sex differences in vascular responsiveness in healthy and trauma patients: contribution of estrogen receptor-mediated Rho kinase and PKC pathways", Am J Physiol Heart Circ Physiol, 306, pp.H1105~H1115 (2014)
- Wang Y, "Activation of protein synthesis in mouse uterine epithelial cells by estradiol-17beta is mediated by a PKC-ERK1", 2-mTOR signaling pathway, 2015, pp.112, E1382~E1391
- O'Mahony F, "Genomic priming of the antisecretory response to estrogen in rat distal colon throughout the estrous cycle", Mol Endocrinol, 23, pp.1885~1899 (2009)
- Khor TO, "Increased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer", Cancer Prev Res(Phila), 1, pp.187~191 (2008)
- Li W, "Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis", Biochem Pharmacol, 76, pp.1485~1489 (2008)
- Niture SK, "Regulation of Nrf2-an update", Free Radic Biol Med, 66, pp.36~44 (2014)
- Zhao C, "Nuclear factor E2-related factor-2(Nrf2)is required for NLRP3 and AIM2inflammasome activation", J Biol Chem, 289, pp.17020~17029 (2014)
- Miao EA, "Caspase-1-induced pyroptotic cell death", Immunol Rev, 243, pp.206~214 (2011)
- Kepp O, "Pyroptosis: a cell death modality of its kind?", Eur J Immunol, 40, pp.627~630 (2010)
- Saleiro D, "Estrogen receptor-beta protects against colitis-associated neoplasia in mice", Int J Cancer, 131, pp.2553~2561 (2012)
- 최윤진, "Açaí Berries Inhibit Colon Tumorigenesis in Azoxymethane", Dextran Sulfate Sodium-Treated Mice, 2017, pp.11(2), 243~252[DOI]
- Suzuki R, "Sequential observations on the occurrence of preneoplastic and neoplastic lesions in mouse colon treated with azoxymethane and dextran sodium sulfate", Cancer Sci, 95, pp.721~727 (2004)
- Lee SE, "Induction of heme oxygenase-1 inhibits cell death in crotonaldehydestimulated HepG2 cells via the PKC-delta-p38-Nrf2 pathway", PLoS One, 7, pp.e41676~ (2012)
- Bratton MR, "Galphao potentiates estrogen receptor alpha activity via the ERK signaling pathway", J Endocrinol, 214, pp.45~54 (2012)
- Ki SH, "Galpha12 specifically regulates COX-2 induction by sphingosine 1-phosphate. Role for JNK-dependent ubiquitination and degradation of IkappaBalpha", J Biol Chem, 282, pp.1938~1947 (2007)
- DiDonato JA, "NF-kappaB and the link between inflammation and cancer", Immunol Rev, 246, pp.379~400 (2012)
- Kalaitzidis D, "Transcription factor cross-talk : the estrogen receptor and NF-kappaB", Trends Endocrinol Metab, 16, pp.46~52 (2005)
- Kim W, "15-Deoxy-delta(12, 14)-prostaglandin J2 exerts proresolving effects through nuclear factor E2-related factor 2-induced expression of CD36 and heme oxygenase-1", Antioxid Redox Signal, 27, pp.1412~1431 (2017)
- Haisenleder DJ, "Estimation of estradiol in mouse serum samples : evaluation of commercial estradiol immunoassays", Endocrinology, 152, pp.4443~4447 (2011)
- Ju Yup Lee, "Repeated Water Avoidance Stress Alters Mucosal Mast Cell Counts, Interleukin-1β Levels with Sex Differences in the Distal Colon of Wistar Rats", Journal of Neurogastroenterology and Motility (JNM), 22(4), pp.694~704 (2016), 대한소화기 기능성질환∙운동학회[DOI]
- Satoh H, "NRF2 intensifies host defense systems to prevent lung carcinogenesis, but after tumor initiation accelerates malignant cell growth", Cancer Res, 76, pp.3088~3096 (2016)
- Fabbi M, "Context-dependent role of IL-18 in cancer biology and counter-regulation by IL-18BP", J Leukoc Biol, 97, pp.665~675 (2015)